If you’re exploring weight loss or metabolic health treatments, you’ve likely heard about the glucagon-like peptide-1 (GLP-1) medications. One of the most talked-about is Tirzepatide. But there’s an important distinction: approved, manufactured versions versus compounded injections. Understanding this difference is key to your safety, health, and achieving the best outcomes. Sunlight provides transparent, science-based, and patient-friendly information to help you move forward confidently.
When used appropriately, Tirzepatide injections have helped many people lower their blood sugar, lose weight, and improve metabolic markers. However, patients may feel uncertain when medications are compounded (custom-mixed at a pharmacy rather than being manufactured directly by the manufacturer under full regulatory approval).
This article explains how tirzepatide works, its benefits, the risks associated with compounding, how to determine if you’re a good candidate, and how Sunlight supports your safe journey.
Tirzepatide is a once-weekly injectable medication that activates two important hormone systems in the body: the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.
Why this matters: For people on the weight-loss journey, especially those with excess weight or metabolic challenges (like pre-diabetes or type 2 diabetes), medications like tirzepatide can offer an important tool alongside diet, movement, and lifestyle changes. At Sunlight, we believe in combining medical science with compassionate support.
Tirzepatide has been shown in clinical studies to significantly lower haemoglobin A1c (a long-term measure of average blood sugar) in adults with type 2 diabetes.
Because tirzepatide slows stomach emptying and signals fullness via the brain, many people on this medication eat less or feel less hungry.
In weight-management trials (for the brand-name version), adults with obesity or overweight (and at least one weight-related condition) lost significant body weight when tirzepatide was used along with diet and increased activity.
For example, the SURPASS‑5 trial showed weight reductions of roughly 5.4 kg at the 5 mg weekly dose and 10.5 kg at the 15 mg weekly dose in adults with type 2 diabetes.
Emerging research suggests tirzepatide may reduce fat build-up in the liver, pancreas, and muscle, helping to improve overall metabolic health.
Always consult your provider before starting or adjusting medication.
Here’s a table that separates more common side effects from more serious but rare risks:
| Common / Mild-to-Moderate Side Effects | Serious / Rare Risks |
|---|---|
| Nausea, vomiting, diarrhea, constipation, stomach discomfort | Pancreatitis (inflammation of the pancreas) |
| Injection-site reactions (redness, irritation) | Medullary thyroid cancer or multiple endocrine neoplasia type 2 (contraindication) |
| Reduced appetite leading to lower food intake | Hypoglycaemia (especially when used with other medications) |
| Slower stomach emptying (which may affect absorption of other meds) | Unknown long-term effects when used on off-label / compounded versions |
Sunlight’s licensed providers monitor patients closely, adjusting doses and checking how you are feeling. That helps ensure safety and the best possible outcome.
You may be a suitable candidate for tirzepatide if:
Because compounded versions of tirzepatide carry specific regulatory and safety concerns (see next section), it’s particularly important to work with a trusted provider who offers approved medications or carefully evaluates any compounded option.
Important note: The Food and Drug Administration (FDA) has signalled concerns about unapproved GLP-1 and GIP/GLP-1 medications being sold or used outside regulatory oversight.
Some key facts:
At Sunlight, safety is our top priority. Our providers use evidence-based treatments, and we ensure any medication is FDA-approved or supplied under full regulatory standards rather than relying on unverified compounded versions.
At Sunlight, we’ve structured our care model around your safety, convenience, and long-term success.
We begin with a detailed online questionnaire and a live consultation with a licensed provider to review your health history, goals, and determine whether tirzepatide is right for you.
If, for a specific reason, a compounded formulation is medically needed — and approved by our provider — we ensure the pharmacy meets high-quality standards, regulatory compliance, and monitoring. In most cases, we favour FDA-approved versions of tirzepatide to reduce risk.
You’ll have regular check-ins, dose adjustments, side-effect monitoring, and support for the lifestyle changes that maximise the medication’s benefits.
Your medication and supplies are shipped securely to your door, with user-friendly instructions, follow-up reminders, and support if you have questions.
Sunlight believes in clear, upfront cost information with no surprises. If insurance covers your treatment, we’ll help navigate that too. We focus on delivering safe, effective solutions that respect your budget and health.
Compounded GLP-1 medications (including tirzepatide) may not have the same regulatory oversight, dosage precision or quality assurance as FDA-approved versions. The FDA has warned about unapproved products.
